Vivakor, Inc. (OTCBB: VIVK) to Pay Dividend

  Vivakor, Inc. (OTCBB: VIVK) announced
yesterday that its Board of Directors approved a dividend to share holders
of record for December 1, 2009. Each shareholder will receive one (1) share
of HealthAmerica, Inc. for every one (1) share of Vivakor, Inc. pending
FINRA approval.

HealthAmerica, Inc. is in the process of developing a patented magnetic resonance imaging (MRI) image resolution enhancing technology called VIVASlices. With the sales of all medical devices slowing, a need for clearer more efficient machines is arising. With the decrease in sales of medical devices like MRIs, facilities are demanding more out of their machines and require them to produce better results.

It is estimated there are between 7,000 and 10,000 MRI machines in use in the United States alone. VIVASlices with its easy to use user interface will work on low, mid and high field magnets, opening it up to all MRI machines in the nation.

For more information, please visit www.vivakor.com

Other active stocks are NBTY Inc. (NYSE: NTY), Health Sciences Group (PINKSHEETS: HESG), and Mindray Medical (NYSE: MR)

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation, do no trading of any kind and send No Faxes or emails.

Contact: Eric Jensen www.ionewswire.com 516.942.4910